You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tas-102

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial (CA102N, TAS-102, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Sep 8, 2023

Pancreatic Tumors Trial in Guangzhou (Surufatinib, TAS-102)

Not yet recruiting
  • Pancreatic Neoplasms
  • Guangzhou, Guangdong, China
    Cancer center of SunYat-sen University
Jul 28, 2022

Immunotherapy, Colorectal Cancer Trial in Fuzhou (Tislelizumab, bevacizumab, TAS-102)

Recruiting
  • Immunotherapy
  • Colorectal Cancer
  • Fuzhou, Fujian, China
  • +1 more
Jul 20, 2022

Colorectal Cancer Trial in Houston (TAS-102)

Recruiting
  • Colorectal Cancer
  • TAS-102
  • Houston, Texas
    MD Anderson Cancer Center
Jun 7, 2022

Colon Cancer, Rectal Cancer, Liver Metastases Trial in San Francisco (Tas-102, SIR-Sphere)

Completed
  • Colon Cancer
  • +2 more
  • Tas-102
  • SIR-Sphere
  • San Francisco, California
    University of California San Francisco
Jul 28, 2022

Metastatic Colorectal Cancer Trial in Fuzhou (Thalidomide, TAS-102)

Recruiting
  • Metastatic Colorectal Cancer
  • Fuzhou, Fujian, China
  • +5 more
Mar 4, 2022

Gastric Adenocarcinoma, GastroEsophageal Cancer Trial in Orange, Sacramento (TAS-102, Irinotecan)

Active, not recruiting
  • Gastric Adenocarcinoma
  • GastroEsophageal Cancer
  • Orange, California
  • +1 more
Apr 4, 2022

Neuroendocrine Tumors, Tumors, Cancer Trial in Madison (TAS-102, Temozolomide, Filgrastim)

Active, not recruiting
  • Neuroendocrine Tumors
  • +3 more
  • TAS-102
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Oct 29, 2021

Refractory Metastatic Colorectal Cancer Trial in Denver, Sarasota, Nashville (TAS-102, nivolumab)

Completed
Has Results
  • Refractory Metastatic Colorectal Cancer
  • Denver, Colorado
  • +2 more
Jul 2, 2021

Colorectal Cancer, Colorectal Carcinoma, Metastatic Cancer Trial in Orange (Cabozantinib, TAS-102)

Recruiting
  • Colorectal Cancer
  • +3 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Sep 30, 2021

Colon Adenocarcinoma, Colorectal Cancer Trial in Orange (drug, combination product, diagnostic test)

Recruiting
  • Colon Adenocarcinoma
  • Colorectal Cancer
  • TAS-102
  • +3 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
May 24, 2022

Advanced Solid Tumors Trial in Czechia, Serbia, United States (TAS-102)

Completed
  • Advanced Solid Tumors
  • TAS-102
  • Phoenix, Arizona
  • +13 more
Jun 15, 2021

Pancreatic Cancer Trial in Gainesville, Tallahassee (TAS-102)

Terminated
Has Results
  • Pancreatic Cancer
  • TAS-102
  • Gainesville, Florida
  • +2 more
Jan 13, 2021

Colorectal Cancer Trial in Boston (TAS-102, Photon SBRT)

Recruiting
  • Colorectal Cancer
  • TAS-102
  • Photon SBRT
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 18, 2021

Colorectal Cancer Trial in China, Korea, Republic of, Thailand (TAS-102, Placebo)

Completed
Has Results
  • Colorectal Cancer
  • TAS-102
  • Placebo
  • Beijing, China
  • +3 more
Oct 23, 2020

Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma Trial in Singapore (TAS-102)

Recruiting
  • Metastatic Nasopharyngeal Carcinoma
  • Recurrent Nasopharyngeal Carcinoma
  • TAS-102
  • Singapore, Singapore
    National University Hospital
Nov 11, 2020

Previously Treated Metastatic Colorectal Cancer Trial in Netherlands, United States (SGI-110 Dose Escalation, Regorafenib,

Completed
Has Results
  • Previously Treated Metastatic Colorectal Cancer
  • SGI-110 Dose Escalation
  • +4 more
  • Los Angeles, California
  • +3 more
Sep 14, 2020

Advanced Solid Tumors Trial in United States (TAS-102)

Completed
  • Advanced Solid Tumors
  • TAS-102
  • Scottsdale, Arizona
  • +7 more
Aug 6, 2020

Colorectal Cancer Trial in China (favezelimab/pembrolizumab, regorafenib, TAS-102)

Recruiting
  • Colorectal Cancer
  • favezelimab/pembrolizumab
  • +2 more
  • Hefei, Anhui, China
  • +23 more
Oct 26, 2022

Colorectal Tumors Trial in Worldwide (Nivolumab-relatlimab FDC, Regorafenib, TAS-102)

Recruiting
  • Colorectal Neoplasms
  • Nivolumab-relatlimab FDC
  • +2 more
  • Rogers, Arkansas
  • +118 more
Aug 16, 2022

Refractory Metastatic Gastric Cancer Trial in Worldwide (TAS-102, Placebo)

Completed
Has Results
  • Refractory Metastatic Gastric Cancer
  • TAS-102
  • Placebo
  • Gilbert, Arizona
  • +138 more
Aug 19, 2021

Colorectal Cancer Trial in Worldwide (favezelimab/pembrolizumab, regorafenib, TAS-102)

Active, not recruiting
  • Colorectal Cancer
  • favezelimab/pembrolizumab
  • +2 more
  • Washington, District of Columbia
  • +151 more
Oct 12, 2022

Colorectal Cancer Trial in Worldwide (TAS-102, Placebo)

Completed
Has Results
  • Colorectal Cancer
  • TAS-102
  • Placebo
  • Glendale, Arizona
  • +114 more
Jun 1, 2020

Metastatic Colorectal Cancer, Colorectal Cancer Metastatic, Carcinoma Trial (Sym004, TAS-102)

Withdrawn
  • Metastatic Colorectal Cancer
  • +2 more
  • (no location specified)
Jan 31, 2019

Metastatic Colorectal Cancer Trial in Washington (TAS-102, Bevacizumab)

Terminated
Has Results
  • Metastatic Colorectal Cancer
  • Washington, District of Columbia
    Georgetown University
Jul 11, 2018